Glucagon-like peptide-1 receptor agonist use is associated with reduced risk of out-of-hospital cardiac arrest in women with type 2 diabetes: A nationwide nested case-control study

Autor: Talip E. Eroglu, Ruben Coronel, Fredrik Folke, Gunnar Gislason

Publikováno v: Resuscitation Plus, Vol 20, Iss , Pp 100821- (2024)

Objective: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) improve cardiovascular outcomes in patients with type 2 diabetes, but few studies have studied the risk of out-of-hospital cardiac arrest (OHCA). We investigated whether GLP-1 RA use re

Externí odkaz: https://doaj.org/article/291d941ff9cc43b9ac0c6db0bb9d4b10

Acetylsalicylic acid use is associated with reduced risk of out-of-hospital cardiac arrest in the general population: Real-world data from a population-based study

Autor: Talip E. Eroglu, Marieke T. Blom, Patrick C. Souverein, Alfi Yasmina, Anthonius de Boer, Hanno L. Tan, for the ESCAPE-NET investigators

Publikováno v: PLoS ONE, Vol 17, Iss 6 (2022)

Aim Activated blood platelet products facilitate myocardial intracellular Ca2+ overload, thereby provoking afterdepolarizations and increasing susceptibility of ischemic myocardium to ventricular fibrillation (VF). These effects are counteracted in v

Externí odkaz: https://doaj.org/article/8d082c23b26641bda0ebb68ad63a608a

Sodium-glucose cotransporter-2 inhibitors compared with glucagon-like-peptide-1 receptor agonists and out-of-hospital cardiac arrest in type 2 diabetes:a nationwide nested case-control study

Autor: Yrsa Kolka Júlíusdóttir, Andrim Halili, Ruben Coronel, Fredrik Folke, Christian Torp-Pedersen, Gunnar Hilmar Gislason, Talip E Eroglu

Publikováno v: Júlíusdóttir, Y K, Halili, A, Coronel, R, Folke, F, Torp-Pedersen, C, Gislason, G H & Eroglu, T E 2023, ' Sodium-glucose cotransporter-2 inhibitors compared with glucagon-like-peptide-1 receptor agonists and out-of-hospital cardiac arrest in type 2 diabetes : a nationwide nested case-control study ', European Heart Journal-Cardiovascular Pharmacotherapy . https://doi.org/10.1093/ehjcvp/pvad033

AimsSodium-glucose cotransporter-2 inhibitors (SGLT-2is) are antidiabetic drugs that have beneficial direct effects on the myocardium by impacting cardiac ion channels and exchangers that control cardiac electrophysiology. We investigated the relatio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33450d668e971b56a564ff4e7be862a3
https://vbn.aau.dk/da/publications/4982b72a-91c1-4b03-8628-abd1e793f00f

Risk of out‐of‐hospital cardiac arrest in patients with epilepsy and users of antiepileptic drugs

Autor: Talip E. Eroglu, Fredrik Folke, Hanno L. Tan, Christian Torp‐Pedersen, Gunnar H. Gislason

Publikováno v: Eroglu, T E, Folke, F, Tan, H L, Torp-Pedersen, C & Gislason, G H 2022, ' Risk of out-of-hospital cardiac arrest in patients with epilepsy and users of antiepileptic drugs ', British Journal of Clinical Pharmacology, vol. 88, no. 8, pp. 3709-3715 . https://doi.org/10.1111/bcp.15313
British journal of clinical pharmacology, 88(8), 3709-3715. Wiley-Blackwell

Aims A few studies suggested that epilepsy and antiepileptic drugs with sodium channel-blocking properties were independently associated with out-of-hospital cardiac arrest (OHCA). However, these findings have not yet been replicated. Methods Using D

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fa33dbd88ce55e46a56e3e463968d45
https://doi.org/10.1111/bcp.15313

Sulfonylurea antidiabetics are associated with lower risk of out-of-hospital cardiac arrest

Autor: Anthonius de Boer, Gerard J.J. Boink, Patrick C. Souverein, Lixia Jia, Hanno L. Tan, Arie O. Verkerk, Marieke T. Blom, Harsha D. Devalla, Talip E Eroglu

Publikováno v: British Journal of Clinical Pharmacology
British Journal of Clinical Pharmacology, 87(9), 3588. NLM (Medline)
British journal of clinical pharmacology, 87(9), 3588-3598. Wiley-Blackwell
British Journal of Clinical Pharmacology, 87(9), 3588-3598. Wiley-Blackwell
Eroglu, T E, Jia, L, Blom, M T, Verkerk, A O, Devalla, H D, Boink, G J J, Souverein, P C, de Boer, A & Tan, H L 2021, ' Sulfonylurea antidiabetics are associated with lower risk of out-of-hospital cardiac arrest : Real-world data from a population-based study ', British Journal of Clinical Pharmacology, vol. 87, no. 9, pp. 3588-3598 . https://doi.org/10.1111/bcp.14774

Aims Out-of-hospital cardiac arrest (OHCA) mostly results from ventricular tachycardia/ventricular fibrillation (VT/VF), often triggered by acute myocardial infarction (AMI). Sulfonylurea (SU) antidiabetics can block myocardial ATP-regulated K+ chann

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f510b0bc3b9545f9ad5e00a85d889e94
http://www.scopus.com/inward/record.url?scp=85104897896&partnerID=8YFLogxK